ALGS

NASDAQStock

Aligos Therapeutics, Inc.

$7.75+0.34 (+4.59%)

52-Week Range

$3.99

$13.29

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

2.75

Volume

34.0K

Avg Volume

38.2K

Performance

+7.24%

-38.25%

-17.21%

YTD

-18.84%

-36.50%

-77.55%

-98.86%

Price Chart

ETF Exposure

ALGS is held by 9 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
AVSC	Avantis U.S. Small Cap Equity ETF	0.00%	1,427	$11K	$2.36B	0.25%
DCOR	Dimensional - US Core Equity 1 ETF	0.00%	1,172	$9K	$2.68B	0.14%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	6	$68	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	223	$2K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$11	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	126,970	$1.0M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	667	$7K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	57	$629	$1.29B	0.17%
VXF	Vanguard Extended Market ETF	0.00%	46,948	$379K	$84.10B	0.05%

About ALGS ETF Exposure

Aligos Therapeutics, Inc. (ALGS) is held by 9 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $7.75. Investors can gain exposure to ALGS through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold ALGS, sorted by portfolio weight.